An IPA of the impact of dx with prediabetes
Research type
Research Study
Full title
An interpretative phenomenological analysis of the impact of being diagnosed with prediabetes
IRAS ID
194949
Contact name
Jaci Huws
Contact email
Sponsor organisation
Bangor University
Duration of Study in the UK
0 years, 7 months, 28 days
Research summary
Prediabetes is a precursor to type 2 diabetes mellitus, both increasing in prevalence worldwide. Prediabetes, often linked closely to obesity and inactivity is a condition where a persons’ blood glucose level is elevated, but not, as yet high enough to be diagnosed as a type 2 diabetic. If prediabetes remains undiagnosed and untreated, it can develop into type 2 diabetes a condition which is treatable but not fully reversible. If timely modifications are made to lifestyle and habits following diagnosis of prediabetes, i.e. increasing daily activity levels, making healthier dietary choices and weight loss, it can inhibit or even stop the development of type 2 diabetes.
This project aims to gain a clearer understanding of how users of primary care who have been diagnosed with prediabetes have made sense of their diagnosis and their experience of living with the diagnosis. Another aim is to gain insight into how their life, if at all has changed following the diagnosis of prediabetes, what interventions led to the changes and what kind of interventions would facilitate further changes to decrease their future risk of type 2 diabetes.
By gaining the correct information, the researcher would hope to develop an intervention/protocol in order to help future users of primary care to facilitate change in their lifestyle and habits to reduce their risk of developing type 2 diabetes.
Eligible participants would be those diagnosed in the previous 12 months, aged between 50 and 65, male or female. Participants must have the ability to understand and communicate in Welsh or English, participants must also be able to give written informed consent. Anyone with a terminal illness, anyone on high dose steroid, anyone with co-morbidities and anyone with learning disabilities because of their vulnerability will be excluded. The study will take place in the participants’ GP practice and should take no longer than 12 months to complete.REC name
Yorkshire & The Humber - Leeds East Research Ethics Committee
REC reference
16/YH/0292
Date of REC Opinion
12 Jul 2016
REC opinion
Favourable Opinion